AI English summary of an SEC filing — figures as filed
Ecolab said the Q3 2026 net sales rose 13% to $4,694.8 million, and adjusted diluted EPS rose 5% to $2.18. Reported diluted EPS fell 5% to $1.95.
Key points
AI summaryEcolab said the Q3 2026 net sales rose 13% to $4,694.8 million, and adjusted diluted EPS rose 5% to $2.18. Reported diluted EPS fell 5% to $1.95.
The company said adjusted diluted EPS included an approximate 10% headwind from CoolIT acquisition-related amortization and financing costs. Reported net interest expense for Q3 was $124.8 million, compared with $55.3 million a year earlier.
The company said organic sales in Global High-Tech grew 63% and organic sales in Life Sciences grew 17% in Q3. Total organic sales growth was 7%, with volume growth at 2% and pricing at 5%.
Ecolab said it expects full-year 2026 adjusted diluted EPS of $8.10 to $8.20, up 8% to 9%, and adjusted diluted EPS for Q4 of $2.13 to $2.23, up 2% to 7%.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q3 Sales and Adjusted Diluted EPS Results
Ecolab said the Q3 2026 net sales rose 13% to $4,694.8 million, and adjusted diluted EPS rose 5% to $2.18. Reported diluted EPS fell 5% to $1.95.
Source · Based on the filing body and exhibits
Higher CoolIT Costs and Interest Expense
The company said adjusted diluted EPS included an approximate 10% headwind from CoolIT acquisition-related amortization and financing costs. Reported net interest expense for Q3 was $124.8 million, compared with $55.3 million a year earlier.
Source · Based on the filing body and exhibits
Segment Organic Growth in Q3
The company said organic sales in Global High-Tech grew 63% and organic sales in Life Sciences grew 17% in Q3. Total organic sales growth was 7%, with volume growth at 2% and pricing at 5%.
Source · Based on the filing body and exhibits
2026 Full-Year and Q4 Outlook
Ecolab said it expects full-year 2026 adjusted diluted EPS of $8.10 to $8.20, up 8% to 9%, and adjusted diluted EPS for Q4 of $2.13 to $2.23, up 2% to 7%.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…